ABSTRACT-Muscle deconditioning is commonly observed in patients surviving sepsis. Little is known regarding the molecular mechanisms regulating muscle protein homeostasis during the recovery or convalescence phase. We adapted a sepsis-recovery mouse model that uses cecal ligation and puncture (CLP), followed 24 h later by cecal resection and antibiotic treatment, to identify putative cellular pathways regulating protein synthesis and breakdown in skeletal muscle. Ten days after CLP, body weight and food consumption did not differ between control and sepsis-recovery mice, but gastrocnemius weight was reduced. During sepsis-recovery, muscle protein synthesis was increased 2-fold and associated with enhanced mTOR kinase activity (4E-BP1 and S6K1 phosphorylation). The sepsis-induced increase in 4E-BP1 was associated with enhanced formation of the eIF4E-eIF4G active cap-dependent complex, while the increased S6K1 was associated with increased phosphorylation of downstream targets S6 and eIF4B. Proximal to mTOR, sepsis-recovery increased Akt and TSC2 phosphorylation, did not alter AMPK phosphorylation, and decreased REDD1 protein content. Despite the decreased mRNA content for the E3 ubiquitin ligases atrogin-1 and muscle RING-finger 1, proteasomal activity was increased 50%. In contrast, sepsis-recovery was associated with an apparent decrease in autophagy (e.g., increased ULK-1 phosphorylation, decreased LCB3-II, and increased p62). The mRNA content for IL-1b, IL-18, TNFa, and IL-6 in muscle was elevated in sepsis-recovery. During recovery after sepsis skeletal muscle responds with an increase in Akt-TSC2-mTOR-dependent protein synthesis and decreased autophagy, but full restoration of muscle protein content may be slowed by the continued stimulation of ubiquitin-proteasome activity.
INTRODUCTION
During the early acute phase of sepsis, there is significant loss of body weight associated with a marked reduction in lean body and skeletal muscle mass (1) . Considerable effort has been expended to better understand the cellular mechanisms responsible for this sepsis-induced cachexia, with the long-term goal of intervening in these processes to prevent or slow the loss of muscle protein and thereby improve contractile function and recovery. Data from a number of independent laboratories are generally consistent and demonstrate that sepsis-induced decreases in muscle protein synthesis and increases in protein degradation are observed 24 to 48 h after cecal ligation and puncture (CLP) (2, 3) . Much of the work in this area has concluded that sepsis impairs protein synthesis via a mammalian target of rapamycin (mTOR)-dependent mechanism while protein breakdown is enhanced by activation of the ubiquitinproteasome pathway (UPP).
Convalescence after severe sepsis in humans may occur over weeks to months, leading to prolonged functional disabilities, cognitive impairment, and impaired quality-adjusted survival (4) (5) (6) . The loss of muscle mass and conditioning is integral to the loss of independence and enhanced frailty in this patient population (7) . Information is limited, however, with respect to the mechanisms and temporal progression by which protein balance and muscle mass are restored after the source of sepsis has been eliminated. Understanding of muscle metabolism and conditioning during convalescence has been hindered by the absence of an animal model that focuses attention on recovery after the removal of the septic source. For the studies reported here, we have adapted a previously reported murine model of sepsis-recovery, which utilizes a classical cecal-ligation-puncture procedure, followed 24 h later by surgical removal of the punctured cecum accompanied by peritoneal lavage and antibiotic administration (8) . Utilizing this model, which should more accurately reflect clinical responses to polymicrobial peritonitis followed by surgical extirpation of the sepsis source, we have performed studies to test the hypothesis that protein synthesis is no longer restrained in post-sepsis recovery, and may be amplified to restore mass and function of skeletal muscle. This model also permitted us to address a complementary hypothesis, that restoration of muscle protein synthesis and mass would require a concurrent dampening of proteolytic activity that is well documented as part of the early response to sepsis.
Experimental design-sepsis recovery
Polymicrobial peritonitis was induced using CLP as previously described (day 0) (8) , with the following modifications. Mice (n ¼ 30) were anesthetized with isoflurane (3%-4% induction with 2%-3% maintenance; Vedco, St. Joseph, Mo) in 100% oxygen. The abdomen was shaved, cleaned with betadine, and a 1 cm midline laparotomy was performed. The cecum was ligated 0.8 cm from the distal end using 4-0 silk (Covidien, Minneapolis, Minn) and punctured twice with a 25-gauge needle. A small amount of cecal material was extruded from the puncture sites to ensure patency, and the cecum was returned to the abdominal cavity. The abdominal wall was sutured closed using 5-0 silk, and the skin was closed with metal wound clips. Mice were resuscitated with 1 mL warm sterile 0.9% saline subcutaneous injection with 0.05 mg/kg buprenorphine (Reckitt Benckiser Pharmaceuticals, Richmond, Va) for postoperative analgesia. Septic mice were allowed free access to both food and water for the remainder of the experiment. Daily body weights and food consumption were measured each morning. Starting 24 h post-CLP (day 1), antibiotic (0.5 mg meropenem; Fresenius Kabi, Lake Zurich, Ill) and buprenorphine were injected subcutaneously (total volume 1 mL of sterile saline) twice daily for the next 5 days (days 1-5). Forty-eight hours post-CLP, mice were anesthetized using isoflurane as above and the original incision was reopened. At this time, the ischemic portion of the cecum distal to the original suture ligation was resected and the abscess around the cecum was removed. The peritoneal cavity was washed with 5 mL warmed saline or until the debris and abscess was cleared. The abdominal incision was closed again in a two-layer fashion. The mice were kept on a warming pad during the procedure and until they regained consciousness. Resuscitation was performed with 1 mL of warmed saline that was injected subcutaneously. Mice were observed through day 10. Sham control mice (n ¼ 10) were pair-fed each morning starting 24 h after the sepsis-recovery mice and provided the quantity of food consumed by the sepsis-recovery mice; however, no less than 0.5 g of chow was provided to the control animals to prevent starvation.
Protein synthesis
In vivo protein synthesis was measured using the nonisotopic SUnSET method (9) , as modified in our laboratory as previously reported (10) . Animals were injected intraperitoneally with puromycin (0.04 mmol/g body weight) dissolved in sterile saline 30 min prior euthanasia. At this relatively low-dose, puromycin is incorporated into elongating peptide chains and the global rate of protein synthesis is estimated by determining the relative amount of puromycinlabeled peptides that are formed (9) . Mice were then deeply anesthetized with isoflurane inhalation as above. The gastrocnemius from both legs was excised and weighed; a portion was immediately homogenized in ice-cold homogenization buffer and the remainder was freeze-clamped and stored at À808C. Because of the amount of tissue needed to assure completion of the analyses described below, no muscle was processed for histological examination. Western blotting was performed using an antipuromycin antibody for the immunological detection of puromycin-labeled peptides (Kerafast, Boston, Mass) that are synthesized during the 30-min period between injection and euthanasia.
Western blotting
Western blot analysis was performed as previously described (10) . Briefly, a portion of fresh gastrocnemius was homogenized in ice-cold homogenizing buffer (20 HEPES (pH 7.4), 2 EGTA, 0.2 EDTA, 100 KCl, 50 b-glycerophosphate, 50 NaF, 0.5 sodium orthovanadate, 1 Benzamidine, 0.1 PMSF, and 1 DTT). The protein concentration of each tissue homogenate was quantified (Bio-Rad Protein Assay, Hercules, Calif) and SDS-PAGE was performed using equal amounts of total protein per sample. Each PDVF membrane was stained with Ponceau S (Aqua Solutions, Deer Park, Tex) to verify equal protein loading. Blots were then blocked in 5% nonfat dry milk, and incubated overnight with primary antibody at 48C. Antibodies included (Cell Signaling, Beverly, Mass, unless otherwise noted): S6K1, S6K1 (Thr389), rpS6, rpS6 (Ser240/244 and Ser230/235), 4E-BP1 (Bethyl Laboratories, Montgomery, Tex), 4E-BP1 (Ser65), eukaryotic elongation factor (eEF)2, eEF2 (Thr56), eEF2 kinase, eEF2K (Ser366; Dr Chris Proud), ERK (extracellular signal-regulated kinses), ERK1/2 (Thr202/Tyr204), RSK (90 kDa ribosomal S6 kinase), RSK1/2 (Ser380), REDD1 (regulated in development and DNA damage responses; ProteinTech, Chicago, Ill), Akt, Akt (Thr308 and Ser473), PRAS40 (proline-rich Akt substrate of 40 kDa), PRAS40 (Thr246), eIF4B, eIF4B (Ser422), AMP-activated protein kinase-a (AMPK), AMPKa (Thr172), tuberous sclerosis complex 2 (TSC2), TSC2 (Thr1462), Unc-51 like autophagy activating kinase 1 (ULK1), ULK1 (Ser757), p62 (aka SQSTM1), light-chain 3B (LC3B)-I and -II, and MyoD and myogenin. Blots were then washed with an appropriate secondary antibody (horseradish peroxidase conjugated goat antirabbit IgG) and developed with enhanced chemiluminescence reagents (Pierce Chemical, Rockford, Ill) according to manufacturer's instruction. Blots were imaged using FluorChem (ProteinSimple, San Jose, Calif) and densities in the linear range were quantified using Image J (NIH, Bethesda, Md). Although only representative Western blots for each protein or phospho-protein are presented in the Results, Western blots were run on and data quantified from the gastrocnemius obtained from all sham controls (n ¼ 10) and sepsis-recovery (n ¼ 17) mice.
Ubiquitin proteasome activity
The Proteasome Activity Fluorometic Assay Kit (BioVision, Milpitas, Calif) was utilized with the following modifications from the manufacturer's instructions. A portion of the gastrocnemius was homogenized and reconstituted in cold Proteasome Assay Buffer provided by the kit that is free of proteasome inhibitors. A portion of the sample was assayed for protein content (BioRad, Hercules, Calif), and 10 mg of protein was loaded into two paired wells, each brought up to 100 mL with additional Assay Buffer. The proteasome substrate was cleaved by proteasome activity and the subsequent release of free AMC was detected by fluorometer (SpectraMax M5; Molecular Devices Corporation, Sunnyvale, Calif). The fluorescence signal (360 nm excitation and 460 nm emission wavelengths) was monitored each 10 min for 2 h at 37 C. Each sample was measured in the presence and absence of the provided proteasome inhibitor to account for non-proteasomal degradation of the substrate, and then subtracted from each measurement. Proteasome chymotrypsin-like activity was calculated by the change in the fluorescence signal, where one unit of activity generates 1.0 nmol of the fluorophore 7-Amino-4-methylcoumarin (AMC) per minute, and data were expressed as activity per mg of protein (nmol/min/mg protein).
RNA extraction and real-time quantitative PCR
Total RNA was isolated using Tri-reagent (Molecular Research Center, Cincinnati, Ohio) and RNeasy mini kit (Qiagen, Valencia, Calif) according to manufacturers' protocol, as previously described by our lab (11) . Residual DNA contamination was removed by on-column DNase I treatment. RNA was eluted from the column with RNase-free water and quantified (NanoDrop 2000, Thermo Fisher Scientific, Waltham, Mass). RNA quality was evaluated on 1% agarose gel. Total RNA (1 mg) was reverse transcribed using superscript III reverse transcriptase (Invitrogen, Carlsbad, Calif). Real-time quantitative PCR was performed using 25 ng of cDNA in StepOnePlus system using TaqMan gene expression assay (Applied Biosystems, Foster, Calif) for: atrogin-1 (aka MAFbx), muscle RING-finger 1 (MuRF1), interleukin (IL)-1b, IL-6, IL-18, tumor necrosis factor (TNF)-a, and insulin-like growth factor (IGF)-I using primers as described previously (10, 12) . The comparative quantitation method 2 -DDCt was used to present gene expression in reference to the endogenous control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Statistical analysis
Data are presented as the mean AE standard error of mean with the number of mice in each group presented in the figure or table legend. Statistical analysis of the data was performed using a two-side t test to compare groups (GraphPad Prism version 6.0, La Jolla, Calif), and group differences were considered significant when P <0.05.
RESULTS

Body weight and food intake
In the sepsis-recovery mice, body weight initially declined 3.5 g over the first 24 h following CLP (Fig. 1A) . A maximal decrease in body weight of the septic mice occurred on day 3, with an average loss of 5 g from the presepsis weight. This decrease in body weight persisted even after the removal of the septic source on day 2 and began to reverse on day 4. In pair-fed control mice, body weight decreases were also observed, reflecting the decreased basal dietary intake observed in sepsis-recovery mice. Throughout most of the study interval, body weight was lower in the sepsis-recovery group, from the time at which CLP was performed until day 9 of the study. However, before CLP/surgery and by day 9 of the study, body weight did not differ between groups.
Before the experiment, all mice had an average basal intake of 4.1 AE 0.3 g of dry food per day (Fig. 1B) . Food intake following sepsis was maximally decreased in the first 24 h following CLP and then steadily increased toward baseline through day 5. On day 5 and through the remainder of the experiment, food consumption was similar to baseline intake (Fig. 1B) . By day 10, there was no difference between the two groups for food intake. Thus, this time point was selected to investigate whether muscle metabolism had returned to basal levels.
Survival
Survival in the sepsis-recovery mice was 57% as 17 of 30 mice survived to day 10 post-CLP. There were no deaths in the first 24 h, and all mice surviving through day 5 completed the FIG. 1. Body weight, food intake, and survival over time in septic mice. A, Change in daily body weight of sepsis-recovery mice compared with time-matched pair-fed control mice. * P <0.05 comparing sepsis-recovery mice to control mice on the same day; values are mean AE SEM. B, Food intake in the sepsis-recovery mice per day which was provided to the control mice for pair-feeding. The horizontal line represents the average basal food intake in these mice prior to experimentation. C, Kaplan-Meier survival curves comparing sepsis-recovery mice to pair-fed control mice. n ¼ 30 initially for sepsis-recovery and 17 mice from days 5 to 10, and n ¼ 10 control mice. CLP indicates cecal ligation and puncture; SEM, standard error of mean. The relative rate of global protein synthesis determined on day 10 was increased more than 2-fold in the gastrocnemius during the sepsis-recovery period compared with pair-fed control values ( Fig. 2A) . At this time point, the mass of the gastrocnemius had not been fully restored and remained 7% lower in the sepsis-recovery group compared with timematched controls (Fig. 2B) .
To investigate the mechanisms potentially contributing to the increased muscle protein synthesis during the recovery phase, the phosphorylation state of substrates involved in the canonical mTOR complex 1 (mTORC1) pathway was assessed (Fig. 3) . The two principle downstream proteins phosphorylated by mTORC1 are 4E-BP1 and S6K1 that stimulate the initiation phase of translation (2) . There was more than a 3-fold increase in phosphorylation of Ser65-phosphorylated 4E-BP1 in gastrocnemius of septic-recovery mice that occurred independent of a change in total 4E-BP1 (Fig. 3, A and B) . The increased 4E-BP1 phosphorylation appeared functionally important as it was associated with a redistribution of eIF4E to the active eIF4E-eIF4G complex (Fig. 3C ) from the relatively inactive eIF4-4EBP1 complex (Fig. 3D) .
S6K1 is also an mTORC1 substrate and Thr389-phosphorylated S6K1 was increased almost 3-fold in septic-recovery mice (Fig. 4A) . There was also an increase in total S6K1 protein (Fig. 4A ) in sepsis-recovery that was smaller in magnitude than the elevation in phosphorylation, yielding a greater than 2-fold increase in the ratio of S6K1 phosphorylated/total (Fig. 4B) . The ribosomal proteins S6 and eIF4B are known substrates for S6K1, and the hyper-phosphorylation and activation of S6K1 is routinely associated with increased phosphorylation these proteins (13) . Thus, the increased S6K1 activity observed in gastrocnemius during sepsis-recovery was substantiated by the coordinated increase in the phosphorylation of both S6 (Ser240/ 244) and eIF4B (Ser422) (Fig. 4A) . Furthermore, during sepsisrecovery there was an increase in the total amount of S6 and eIF4B. Hence, during the recovery period, the increase in S6K1 activity was sufficient to phosphorylate increasing amounts of these two substrates. Accordingly, the ratio of phosphorylated/ total for both S6 and eIF4B was elevated in sepsis-recovery compared with control values (Fig. 4, C and D) .
S6K1 is also known to phosphorylate eEF2K at Ser366 (13) . Such an increase eEF2K phosphorylation was detected in gastrocnemius during sepsis-recovery, compared with control values (Fig. 4, A and E) . The phosphorylation of eEF2K at this site inhibits its kinase activity (14) , and this was confirmed by the concomitant reduction in Thr56-phosphorylated eEF2 (Fig. 4, A and F) . It is noteworthy that the decrease in the ratio of phosphorylated/total eEF2 observed during sepsisrecovery was entirely due to the increase in total eEF2 protein (Fig. 4A) .
Activation of the ERK pathway can also stimulate protein synthesis via phosphorylation of S6 on Ser235/236 (15) , and phosphorylation of this site on S6 was increased in muscle during sepsis-recovery (Fig. 5, A and B) . However, phosphorylation of ERK1/2 (Thr202/Tyr204) and its downstream substrate RSK1/2 (Ser380) was decreased in gastrocnemius during sepsis-recovery, compared with time-matched control values (Fig. 5, C and D) .
We also assessed the phosphorylation state of upstream proteins central to mTORC1 regulation. The increase in mTORC1 activity was associated with an increased phosphorylation of Akt at both Thr473 (Fig. 6B) and Thr308 (Fig. 6C ) in muscle during recovery from sepsis. There was a concomitant increase in Thr1462 phosphorylation of the Aktdependent site on TSC2 (Fig. 6D) . In contrast, the phosphorylation of PRAS40, another Akt substrate, did not differ between sepsis-recovery and control mice (Fig. 6A) . Likewise, there was no change in Thr172-phosphorylated AMPK between groups (Fig. 6E) . Finally, in contrast, there was more than a 50% decrease in REDD1, an mTORC1 inhibitory protein (16) , in muscle during sepsis-recovery (Fig. 6F) .
Protein breakdown
Total protein content can be regulated by a change in either protein synthesis and/or protein breakdown. Proteasomal activity is reported to be the principle component of global protein degradation in catabolic states, and the ubiquitin-E3 ligases atrogin-1 and MuRF1 are frequently upregulated in a FoxO1-dependent manner (17) . There was an increase in phosphorylated FoxO1 in sepsis-recovery, independent of a change in the total amount of this transcription factor. Because the reliability of antibodies for Western analysis could not be confirmed, we only assessed mRNA content for the two E3 ligases. There was a greater than 50% decrease in atrogin-1 and MuRF1 mRNA in gastrocnemius during sepsis-recovery (Fig. 7, B and C) . In contradistinction, in vitro-determined proteasomal activity was increased in muscle from mice recovering from sepsis (Fig. 7D ).
An alteration in mTORC1 activity can inversely regulate autophagy at least in part by phosphorylating ULK1 (18) . In this regard, Ser757-phosphorylated ULK-1 was increased during recovery from sepsis (Fig. 8A ) in conjunction with a marked reduction in the LC3B-II and increase in p62 (SQSTM1) content (Fig. 8, B and C) . Collectively, these data are consistent with an inhibition of autophagy.
Muscle cytokines
Localized muscle inflammation, as assessed by cytokine mRNA expression, was also determined as these immunomodulatory proteins can regulate muscle protein synthesis and degradation (19) . During sepsis-recovery, the mRNA content for IL-1b, IL-18, TNFa, and IL-6 was all elevated, compared with time-matched control values (Fig. 9, A-D) . Similarly, the IGF-I mRNA content in muscle was also increased during sepsis-recovery (Fig. 9E) .
Myogenic proliferation
Satellite cells in resting skeletal muscle are quiescent but can be rapidly activated in damaged muscle (20) . To determine whether satellite cells were activated during the recovery phase of sepsis, we assessed MyoD and myogenin protein content.
Western blot analysis indicated that the relative protein content for MyoD (Control ¼ 100 AE 5 AU vs. Sepsis ¼ 103 AE 9 AU) and myogenin (Control ¼ 100 AE 14 AU vs. Sepsis 104 AE 11 AU) was not statistically different in skeletal muscle from control and sepsis-recovery mice (representative blots not shown).
DISCUSSION
The present data characterize critical components of major signal transduction pathways pertaining to the regulation of skeletal muscle protein balance during the recovery phase after sepsis. Our data demonstrate during convalescence from sepsis there is a period of over-compensation where muscle protein synthesis is elevated above basal control levels, and this increase is mediated by activation of Akt-TSC2-mTORC1 signal transduction. Additionally, there were divergent effects on pathways modulating muscle protein breakdown as evidenced by an increase in the UPP, which appears independent of increases in atrogin-1 and MuRF1, but a decrease in autophagy. As control mice were pair-fed to septic mice, these changes cannot be attributed to the temporary interval of anorexia following induction of sepsis. Based on the data presented herein, we propose a model (Fig. 10 ) whereby putative signal transduction pathways are activated or inhibited in skeletal muscle during the recovery from sepsis and that may be necessary for reestablishing protein homeostasis in this tissue.
In this mouse model of sepsis-recovery, there is increased phosphorylation of Akt at both Thr308 and Ser473 that is necessary for full activation (21) . Although Akt phosphorylates numerous proteins, it is responsible forThr1462 phosphorylation of TSC2 leading to the inactivation of this inhibitory protein, thereby increasing the kinase activity of mTORC1 (22) . Hence, the increased phosphorylation of Akt, TSC2 and the mTOR substrates 4E-BP1 and S6K1 are entirely consistent with activation of this protein synthetic pathway. Moreover, the recovery-induced increase in 4E-BP1 and S6K1 phosphorylation appears functionally active. For example, 4E-BP1 is considered a translational repressor since the un-or hypophosphorylated form preferentially binds eIF4E (23) . However, the increased phosphorylation of 4E-BP1 during the recovery from sepsis is consistent with the dissociation of eIF4E from phosphorylated 4E-BP1 and the increased formation of the active eIF4E-eIF4G complex that stimulates cap-dependent translation. Moreover, the increased phosphorylation of S6 (Ser240/244), eIF4B (Ser422), and eEF2K (Ser366) attests to the enhanced activity of S6K1. Activating the Akt-TSC2-mTORC1 pathway appears to represent a compensatory upregulation during the recovery phase that is capable of enhancing protein synthesis via a coordinated increase of both the initiation and elongation phase of translation. The activation of this canonical pathway is notable as it represents a complete reversal of the hypophosphorylation of Akt, mTOR, 4E-BP1 and S6K1, eIF4B, and eEF2K detected acutely in muscle at 24 h after CLP (12, 24) .
During recovery we also detected an increased phosphorylation of the ribosomal protein S6 at Ser235/236 which initially suggested the stimulation of the Ras-mitogen-activated protein kinase (MAPK) pathway (25) . An increased phosphorylation of S6 at Ser235/236 has been reported to regulate recruitment to the 7-methylguanosine cap complex and represents an mTORC1-independent mechanism for enhancing translation (25) . The decreased phosphorylation of ERK1/2 and RSK1/2 suggests the increased phosphorylation of S6 at Ser235/S236 was MAPK-independent. The sepsis-induced decrease in ERK1/2 phosphorylation represents an early event (26) that is sustained during the recovery phase. These findings are FIG. 7 . Change in the ubiquitin proteasome pathway in gastrocnemius during sepsis-recovery. Representative Western blot for phosphorylated and total FoxO1 and bar graph presents quantitation of all blots for phosphorylated FoxO1/total FoxO1, and the control value set at 100 AU (A). Using QT-PCR, mRNA content of muscle-specific E3 ligases Atrogin-1 (B), and MuRF1 (C) were normalized to GAPDH in gastrocnemius. Proteasome activity in gastrocnemius was also quantitated (D). Values are mean AE SEM. counter to the increased ERK/RSK phosphorylation seen in response to muscle regrowth in other conditions (27) . Moreover, as activation of the ERK pathway is typically observed in conditions where muscle stem cells (e.g., satellite cells) are activated (20) , and the markers of satellite cell activation MyoD and myogenin did not differ between control and sepsis-recovery mice, we have no data to suggest the restoration of muscle mass is mediated by the of proliferation satellite cells and/or myogenic progenitor cells.
Acute sepsis (24-h post-CLP) increases AMPK phosphorylation and REDD1 protein content in skeletal muscle (24) which is associated with inhibition of mTORC1. However, in the recovery phase, AMPK phosphorylation did not differ from control levels and we detected a decrease in total REDD1. Previous studies have indicated that knockdown of REDD1 protein largely prevents the acute sepsis-induced decrease in muscle protein synthesis (12) . Moreover, knockdown of REDD1 also activates (phosphorylates) Akt, thereby stimulating mTORC1 (28) . Collectively, these data reveal that the decrease in REDD1 may represent a major mechanism by which muscle protein synthesis is upregulated during recovery from sepsis.
Alterations in protein breakdown are also causally related to the loss of muscle mass in some catabolic conditions (3). Although our characterization of proteolytic pathways was not as fully detailed as for protein synthesis, novel data were obtained in this regard. Activation of Akt during sepsis-recovery was associated with a concomitant increase in Ser256-phosphorylation of FoxO1, a change consistent with the known regulation of this transcription factor by Akt in response to insulin and anabolic agents (29) . Moreover, as this increase prevents the translocation of FoxO1 into the nucleus, it may at least partially explain the reduction in mRNA content for the muscle-specific E3 ligases, atrogin-1, and MuRF1. The mRNA levels for these two proteins have routinely been used as surrogate markers for the ubiquitin-proteasome pathway. Therefore, it was somewhat unexpected that muscle proteasomal activity was found to be increased during sepsis-recovery. However, accumulating evidence now suggests that it is often erroneous to equate changes in atrogin-1 and MuRF1 with coordinated changes in proteasomal activity and protein degradation (30) . In a previously published model, where rats received a single intravenous injection of live E coli, proteasomal activity was increased at 6 days postinfection but UPP activity had returned to basal levels by day 10 (31). The apparent discrepancy between these studies may be related to the greater severity and/or complexity of the initial polymicrobial septic insult and cecal resection performed in our current study. Hence, our data indicate the increase in proteolysis is one alteration seen in the acute phase that is sustained and manifested during recovery. This observation offers the possibility that the mechanism responsible for the increased UPP-mediated proteolysis may provide suitable targets for therapeutics directed at enhancing muscle recovery.
Autophagy also degrades cellular organelles and protein and is tightly controlled by mTORC1 and AMPK (32) . As AMPK phosphorylation in muscle did not differ between control and sepsis-recovery mice, the increased mTORC1 kinase activity is likely responsible for the increased Ser757 phosphorylation of ULK1 and is consistent with the concomitant decrease in the amount of lipidated LC3B-II. We also detected an increase in p62 protein in sepsis-recovery which suggests a decrease in autophagosome production and autophagy. As opposed to the sustained elevation in proteasomal activity, the early increase in autophagy seen 24 h after CLP appears to have abated during the recovery phase, potentially suggesting that the need to remove damaged proteins and mitochondria has waned. Hence, during sepsis-recovery the two major pathways for protein breakdown are differentially controlled-with sepsis increasing UPP and decreasing autophagy.
The cytokine milieu in skeletal muscle can govern protein homeostasis (19) . The magnitude of the increase in IL-1b and TNFa mRNA during sepsis-recovery was comparable to that previously reported 24 h after CLP (12) . In contrast, IL-6 mRNA was only increased about 50% during sepsis-recovery which is markedly lower than the 10-fold elevation in IL-6 detected in gastrocnemius during the acute phase of sepsis (12) . Sepsis-induced alterations in muscle IL-18 mRNA have not been previously reported, although they are elevated in other wasting diseases (33) . These data indicate that muscle is capable of elevated rates of protein synthesis in the presence of elevated expression of intramuscular cytokines. Accordingly, based on the known regulatory role of IL-6 in muscle wasting (34), we speculate that the considerably lower expression of IL-6 mRNA during the recovery versus the acute phase of sepsis may no longer be sufficient to impair protein synthesis. Finally, IGF-I is both an autocrine/paracrine and endocrine anabolic mediator (35) and the elevation in muscle proinflammatory cytokines in acute sepsis is typically associated with a reduction in muscle IGF-I mRNA and protein content (12) . The elevation of muscle IGF-I during sepsisrecovery not only suggests resolution of the inflammatory state but also the re-establishment of an anabolic milieu that may aid to restore muscle protein balance.
In these studies, we have identified the signal transduction pathways that likely serve as drivers of restoration of muscle mass during convalesce from sepsis. Activation of the Akt-TSC2-mTORC1 pathway, possibly via a reduction in REDD1, stimulates muscle protein synthesis via coordinated increases in translation initiation and elongation and cap-dependent translation. Furthermore, while the increase in mTORC1 also decreased muscle autophagy, full restoration of muscle mass during sepsis recovery appears to be delayed by the continued stimulation of the ubiquitin-proteasome pathway which appears independent of alterations in the muscle-specific E3 ligases atrogin-1 and MuRF1. Our findings offer the possibility that UPP-mediated proteolysis and REDD1 might serve as therapeutic targets for enhancing net protein accretion and limit muscle deconditioning, once the source of sepsis has been controlled. Our studies also provide evidence that the convalescence phase following sepsis should not be viewed simply as a restoration of the pre-sepsis balance between protein synthesis and catabolism.
